Skip to main content
. 2020 Feb 17;4(2):150–158. doi: 10.1016/j.mayocpiqo.2019.11.001

Table 2.

Physician Knowledge and Attitudes About UTxa

Variable No. (%) of respondents
Heard of UTx (N=447)
 Yes 279 (62.4)
 No 168 (37.6)
Heard about UTx from (N=343)
 Social media or news source 184 (53.6)
 Medical society 87 (25.4)
 Other 72 (21.0)
UTx is relevant to practice (N=446)
 Yes 80 (17.9)
 No 228 (51.1)
 Maybe 138 (30.9)
Would introduce UTx to AUFI patient (N=446)
 Yes 160 (35.9)
 No 81 (18.2)
 Maybe 205 (46.0)
UTx for pregnancy is ethically justifiable (N=433)
 Yes 195 (45.0)
 No 44 (10.2)
 Under certain circumstances 94 (21.7)
 Not sure 100 (23.1)
Moral and ethical factors in UTx (N=1661)b
 Religious perspectives 129 (7.8)
 Risk to donor 331 (19.9)
 Risk to recipient 393 (23.7)
 Risk to child 342 (20.6)
 Use of medical resources 284 (17.1)
 Importance of reproduction 165 (9.9)
 Other 17 (1.0)
Regulation of UTx (N=863)b
 Institution 136 (15.8)
 Professional societies 177 (20.5)
 Similar to other solid organ transplants 318 (36.8)
 FDA 195 (22.6)
 Other 37 (4.3)
Financial coverage of infertility treatment (N=411)
 Individual 160 (38.9)
 Institution 3 (0.7)
 Private insurance 186 (45.3)
 Medicaid 4 (1.0)
 Other 58 (14.1)
Financial coverage of UTx (N=413)
 Individual 193 (46.7)
 Institution 6 (1.5)
 Private insurance 147 (35.6)
 Medicaid 3 (0.7)
 Other 64 (15.5)
a

AUFI = absolute uterine factor infertility; FDA = US Food and Drug Administration; UTx = uterus transplant.

b

Participants were allowed to choose more than one answer.